| Charles B Pasque, MD | |
|
825 Ne 10th St, Oupb1300, Oklahoma City, OK 73104-5417 | |
| (405) 271-6667 | |
| Not Available |
| Full Name | Charles B Pasque |
|---|---|
| Gender | Male |
| Speciality | Sports Medicine |
| Experience | 35 Years |
| Location | 825 Ne 10th St, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801864319 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 17273 (Oklahoma) | Primary |
| 207XX0005X | Orthopaedic Surgery - Sports Medicine | 17273 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| O U Medical Center | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ou Health Partners Inc | 5991105876 | 779 |
News Archive
A search using medical data bases reveals that hundreds of meta-analysis papers conducted with tens of millions of people worldwide have confirmed clinically the efficacies of thirty antioxidant-rich foods to prevent or treat chronic diseases, including hypertension, diabetes, cardiovascular disease, cognitive impairment, chronic kidney disease, cancer, and more.
Bristol-Myers Squibb Company announced today that it has entered into a clinical collaboration agreement with Tibotec Pharmaceuticals to evaluate the utility of daclatasvir (BMS-790052), Bristol-Myers Squibb's investigational NS5A replication complex inhibitor, in combination with Tibotec Pharmaceuticals' investigational NS3 protease inhibitor, TMC435, for the treatment of chronic hepatitis C virus (HCV).
Disturbances in the early stages of brain growth, such as preterm birth - when many of the brain's structures have not yet fully developed - appears to affect the brain's neuro-circuitry, which may explain premature babies' higher risk of neurodevelopmental disorders including ADHD and autism spectrum disorder.
Incarcerated individuals with chronic hepatitis C virus infection can be successfully treated with pegylated interferon and ribavirin, achieving similar rates of treatment completion and sustained viral response to that of infected individuals in the community, study results show.
› Verified 2 days ago
| Entity Name | Board Of Regents Of The University Of Oklahoma - Ou Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801869250 PECOS PAC ID: 2860304334 Enrollment ID: O20031103000607 |
News Archive
A search using medical data bases reveals that hundreds of meta-analysis papers conducted with tens of millions of people worldwide have confirmed clinically the efficacies of thirty antioxidant-rich foods to prevent or treat chronic diseases, including hypertension, diabetes, cardiovascular disease, cognitive impairment, chronic kidney disease, cancer, and more.
Bristol-Myers Squibb Company announced today that it has entered into a clinical collaboration agreement with Tibotec Pharmaceuticals to evaluate the utility of daclatasvir (BMS-790052), Bristol-Myers Squibb's investigational NS5A replication complex inhibitor, in combination with Tibotec Pharmaceuticals' investigational NS3 protease inhibitor, TMC435, for the treatment of chronic hepatitis C virus (HCV).
Disturbances in the early stages of brain growth, such as preterm birth - when many of the brain's structures have not yet fully developed - appears to affect the brain's neuro-circuitry, which may explain premature babies' higher risk of neurodevelopmental disorders including ADHD and autism spectrum disorder.
Incarcerated individuals with chronic hepatitis C virus infection can be successfully treated with pegylated interferon and ribavirin, achieving similar rates of treatment completion and sustained viral response to that of infected individuals in the community, study results show.
› Verified 2 days ago
| Entity Name | Ou Health Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528642642 PECOS PAC ID: 5991105876 Enrollment ID: O20210615000618 |
News Archive
A search using medical data bases reveals that hundreds of meta-analysis papers conducted with tens of millions of people worldwide have confirmed clinically the efficacies of thirty antioxidant-rich foods to prevent or treat chronic diseases, including hypertension, diabetes, cardiovascular disease, cognitive impairment, chronic kidney disease, cancer, and more.
Bristol-Myers Squibb Company announced today that it has entered into a clinical collaboration agreement with Tibotec Pharmaceuticals to evaluate the utility of daclatasvir (BMS-790052), Bristol-Myers Squibb's investigational NS5A replication complex inhibitor, in combination with Tibotec Pharmaceuticals' investigational NS3 protease inhibitor, TMC435, for the treatment of chronic hepatitis C virus (HCV).
Disturbances in the early stages of brain growth, such as preterm birth - when many of the brain's structures have not yet fully developed - appears to affect the brain's neuro-circuitry, which may explain premature babies' higher risk of neurodevelopmental disorders including ADHD and autism spectrum disorder.
Incarcerated individuals with chronic hepatitis C virus infection can be successfully treated with pegylated interferon and ribavirin, achieving similar rates of treatment completion and sustained viral response to that of infected individuals in the community, study results show.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles B Pasque, MD 1122 Ne 13th St, Ori236, Oklahoma City, OK 73117-1039 Ph: (405) 271-1515 | Charles B Pasque, MD 825 Ne 10th St, Oupb1300, Oklahoma City, OK 73104-5417 Ph: (405) 271-6667 |
News Archive
A search using medical data bases reveals that hundreds of meta-analysis papers conducted with tens of millions of people worldwide have confirmed clinically the efficacies of thirty antioxidant-rich foods to prevent or treat chronic diseases, including hypertension, diabetes, cardiovascular disease, cognitive impairment, chronic kidney disease, cancer, and more.
Bristol-Myers Squibb Company announced today that it has entered into a clinical collaboration agreement with Tibotec Pharmaceuticals to evaluate the utility of daclatasvir (BMS-790052), Bristol-Myers Squibb's investigational NS5A replication complex inhibitor, in combination with Tibotec Pharmaceuticals' investigational NS3 protease inhibitor, TMC435, for the treatment of chronic hepatitis C virus (HCV).
Disturbances in the early stages of brain growth, such as preterm birth - when many of the brain's structures have not yet fully developed - appears to affect the brain's neuro-circuitry, which may explain premature babies' higher risk of neurodevelopmental disorders including ADHD and autism spectrum disorder.
Incarcerated individuals with chronic hepatitis C virus infection can be successfully treated with pegylated interferon and ribavirin, achieving similar rates of treatment completion and sustained viral response to that of infected individuals in the community, study results show.
› Verified 2 days ago
Dr. Kimberly S Smith, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 13100 N Western Ave Ste 200, Oklahoma City, OK 73114 Phone: 405-749-5025 Fax: 405-749-3585 | |
Mr. Nathan E Bradley, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3301 N.w. 50th St, Oklahoma City, OK 73112 Phone: 405-947-0911 | |
Thomas Craddock Howard Iii, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 9600 Broadway Ext, Oklahoma City, OK 73114 Phone: 405-230-9412 Fax: 405-230-9157 | |
Richard J Langerman Jr., DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 8100 S Walker Ave Bldg A, Oklahoma City, OK 73139 Phone: 405-632-4468 Fax: 405-632-0436 | |
Dr. Rishi Thakral, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 825 Ne 10th St, Oupb 1c, Oklahoma City, OK 73104 Phone: 405-271-2663 Fax: 405-271-6762 | |
Dr. William Austin Doss, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5401 N Portland Ave # 600, Oklahoma City, OK 73112 Phone: 405-713-9941 | |
Paul Alan Kammerlocher, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3115 Sw 89th St, Oklahoma City, OK 73159 Phone: 405-486-6900 Fax: 405-486-6839 |